Top Funding Rounds: Biotech and AI Lead with Big Wins
Biotech and AI sectors see major funding, with Candid Therapeutics' $370M and Glean's $260M rounds leading the way this week.
- Latest
- Trending
Biotech and AI sectors see major funding, with Candid Therapeutics' $370M and Glean's $260M rounds leading the way this week.
Artivion reports 10% revenue growth, raises 2024 guidance. Key products and market expansion drive success.
Asensus Surgical's Q2 report highlights revenue increase, net loss, and crucial merger vote with KARL STORZ.
FDA plans to clear numerous AI algorithms, enhancing healthcare through advanced technology regulation and streamlined processes.
InspireMD reports revenue growth in Q2 2024 and plans to launch CGuard Prime in the US by 2025, despite current ...
Maccabi Healthcare adopts Cynerio's platform to protect IoT systems, ensuring data security and service continuity.
DARPA's AI Cyber Challenge heats up, with healthcare sector keenly watching. $29.5m in prizes for the best AI systems tackling ...
Novanta Inc. surpasses market expectations with a 3% revenue growth in Q2 2024. Adjusted EBITDA and operating cash flow also ...
Interlynk to provide SBOM generation, vulnerability reporting, and risk assessment for BIOTRONIK's life-saving products.
Semler Scientific adopts bitcoin strategy after studying MicroStrategy. Plans to invest more with SEC approval for capital raise.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.